BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1268065)

  • 21. Corticosteroid-induced dermal atrophy in the rat.
    Young JM; Yoxall BE; Wagner BM
    J Invest Dermatol; 1977 Nov; 69(5):458-62. PubMed ID: 908845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penetration of various corticosteroids through epidermis in vitro.
    Ponec M; Polano MK
    Arch Dermatol Res; 1979 May; 265(1):101-4. PubMed ID: 475440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels.
    Barry BW; Woodford R
    Br J Dermatol; 1974 Sep; 91(3):323-38. PubMed ID: 4611447
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the effect of hydrocortisone, hydrocortisone-17-butyrate and betamethasone on collagen synthesis in human skin in vivo.
    Haapasaari KM; Risteli J; Koivukangas V; Oikarinen A
    Acta Derm Venereol; 1995 Jul; 75(4):269-71. PubMed ID: 8578945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
    Prakash A; Benfield P
    Drugs; 1998 Jan; 55(1):145-63. PubMed ID: 9463794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newer topical therapy in dermatology.
    Bluefarb SM
    Int J Dermatol; 1970; 9(3):200-8. PubMed ID: 5476381
    [No Abstract]   [Full Text] [Related]  

  • 27. Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure.
    Williamson J; Eilon LA; Walker SR
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):27-9. PubMed ID: 6764318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrocortisone 17-butyrate: a new topical corticosteroid preliminary report.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976; 12(4):249-57. PubMed ID: 786608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the effectiveness of locally administered corticosteroids].
    Semrádová V; Horácek J
    Cesk Dermatol; 1974 Jul; 49(4):222-6. PubMed ID: 4844681
    [No Abstract]   [Full Text] [Related]  

  • 30. Vasoconstrictor and systemic activities of topical steroids.
    Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA
    Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856
    [No Abstract]   [Full Text] [Related]  

  • 31. The hairless mouse as a model for study of local and systemic atrophogenic effects following topical application of corticosteroids.
    van den Hoven WE; van den Berg TP; Korstanje C
    Acta Derm Venereol; 1991; 71(1):29-31. PubMed ID: 1676210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Halogenation and topical corticosteroids: a comparison between the 17-butyrate esters of hydrocortisone and clobetasone in ointment bases.
    Allenby CF; Sparkes CG
    Br J Dermatol; 1981 Feb; 104(2):179-83. PubMed ID: 7011356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Remarks on the percutaneous absorption of corticoids].
    Rimbaud P; Meynadier J
    Ann Dermatol Syphiligr (Paris); 1968; 95(3):263-7. PubMed ID: 5697207
    [No Abstract]   [Full Text] [Related]  

  • 34. Clobetasone butyrate and hydrocortisone butyrate in the treatment of eczema: a double-blind comparison.
    Lassus A
    Curr Med Res Opin; 1979; 6(3):165-7. PubMed ID: 391489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation.
    Ishikawa H; Mori Y; Tsurufuji S
    Eur J Pharmacol; 1969 Aug; 7(2):201-5. PubMed ID: 5345995
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of contact sensitivity in the mouse by topical application of corticosteroids.
    Evans DP; Hossack M; Thomson DS
    Br J Pharmacol; 1971 Oct; 43(2):403-8. PubMed ID: 5158205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of corticosteroids on the growth and metabolism of fibroblasts cultured from human skin.
    Priestley GC
    Br J Dermatol; 1978 Sep; 99(3):253-61. PubMed ID: 81679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
    Marks R
    Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eumovate (clobetasone butyrate 0.05%) cream: a review of clinical efficacy and safety.
    Goustas P; Cork MJ; Higson D
    J Dermatolog Treat; 2003 Jun; 14(2):71-85. PubMed ID: 12775314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticosteroid-induced inhibition of the biosynthesis of human skin collagen.
    Uitto J; Teir H; Mustakallio KK
    Biochem Pharmacol; 1972 Aug; 21(16):2161-7. PubMed ID: 4646188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.